FDA.reportPublic FDA data

raltegravir 100 MG Granules for Oral Suspension [Isentress]

RxCUI
1486841
RxNorm name
raltegravir 100 MG Granules for Oral Suspension [Isentress]
Display name
raltegravir 100 MG Granules for Oral Suspension [Isentress]
Full name
raltegravir 100 MG Granules for Oral Suspension [Isentress]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89a5ec53-d956-4329-8004-0f40f51c88a3Isentress 100 MG Granules for Oral Suspension [PSN] · raltegravir 100 MG Granules for Oral Suspension [Isentress] [SBD] · Isentress (raltegravir 100 MG (as raltegravir potassium 108.8 MG)) Granules for Oral Suspension [SY] · Isentress 100 MG Granules for Oral Suspension [SY]470These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) film-coated tablets, for oral use ISENTRESS ® HD (raltegravir) film-coated tablets, for oral use ISENTRESS ® (raltegravir) chewable tablets, for oral use ISENTRESS ® (raltegravir) for oral suspension Initial U.S. Approval: 200720241018